Lundbeck has a broad range of products within brain diseases, with registered products in more than 100 countries.

Reporting of potential adverse drug reactions is important in order for us to continuously evaluate the benefits and risks of our products and take proactive action as warranted.

Our partners represent expertise from several scientific areas.

Visit our Global site to find out about our products that are registered in more than 100 countries.